We are live on ! Find out more
NMTC icon

NeuroOne Medical Technologies

37 hedge funds and large institutions have $9.44M invested in NeuroOne Medical Technologies in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

9% more funds holding

Funds holding: 3437 (+3)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

0.69% less ownership

Funds ownership: 4.8%4.12% (-0.69%)

26% less capital invested

Capital invested by funds: $12.8M → $9.44M (-$3.36M)

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
9
Reduced
9
Closed
5
Calls
$88K
Puts
Net Calls
+$88K
Net Calls Change
+$21K

NMTC Hedge Fund Activity: Q4 2025 in Review

37 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q4 2025, worth a combined $9.44M — down 26% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NMTC positions and 5 closed out — a net gain of 3 holders — while 9 added to existing stakes and 9 trimmed.

The largest buyer was Essex Investment Management, opening a new position worth an estimated $143K. The largest seller was Sio Capital Management, cutting an estimated $927K.

  • 37 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q4 2025, up from 34 in Q3 2025.
  • Funds reported $9.44M of NeuroOne Medical Technologies stock for Q4 2025, down 26% quarter-over-quarter.
  • 8 funds opened new NeuroOne Medical Technologies positions in Q4 2025 and 5 closed out, a net change of +3 holders.
  • The largest NeuroOne Medical Technologies buyer in Q4 2025 was Essex Investment Management, an estimated $143K added.
  • The largest NeuroOne Medical Technologies seller in Q4 2025 was Sio Capital Management, an estimated $927K sold.

Based on aggregated 13F filings for Q4 2025.